IN2012DN02126A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02126A
IN2012DN02126A IN2126DEN2012A IN2012DN02126A IN 2012DN02126 A IN2012DN02126 A IN 2012DN02126A IN 2126DEN2012 A IN2126DEN2012 A IN 2126DEN2012A IN 2012DN02126 A IN2012DN02126 A IN 2012DN02126A
Authority
IN
India
Prior art keywords
compound
diagnostic
composition
pharmaceutically acceptable
acceptable carrier
Prior art date
Application number
Other languages
English (en)
Inventor
Wistrand Lars-Goran
Thaning Mikkel
Newton Ben
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of IN2012DN02126A publication Critical patent/IN2012DN02126A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452Solutions, e.g. for injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
IN2126DEN2012 2009-10-29 2010-10-28 IN2012DN02126A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09174413 2009-10-29
PCT/EP2010/066351 WO2011051387A1 (en) 2009-10-29 2010-10-28 Diagnostic composition comprising plasma cations having superior safety profile

Publications (1)

Publication Number Publication Date
IN2012DN02126A true IN2012DN02126A (es) 2015-08-21

Family

ID=43503035

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2126DEN2012 IN2012DN02126A (es) 2009-10-29 2010-10-28

Country Status (21)

Country Link
US (1) US8815210B2 (es)
EP (1) EP2493511B1 (es)
JP (1) JP5335147B2 (es)
KR (1) KR101545045B1 (es)
CN (1) CN102596257B (es)
AU (1) AU2010311478B2 (es)
BR (1) BR112012009859B1 (es)
CA (1) CA2773685C (es)
CO (1) CO6531477A2 (es)
DK (1) DK2493511T3 (es)
ES (1) ES2435299T3 (es)
HR (1) HRP20130991T1 (es)
IL (1) IL218456A (es)
IN (1) IN2012DN02126A (es)
MX (1) MX2012005021A (es)
NZ (1) NZ598540A (es)
PL (1) PL2493511T3 (es)
PT (1) PT2493511E (es)
RU (1) RU2544113C2 (es)
WO (1) WO2011051387A1 (es)
ZA (1) ZA201203505B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO333914B1 (no) * 2011-12-21 2013-10-21 Ge Healthcare As Stabilisering av diagnostisk røntgensammensetning
AU2013208955B2 (en) * 2012-01-11 2017-11-16 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and X-ray imaging process
CN105579069A (zh) * 2013-03-27 2016-05-11 通用电气医疗集团股份有限公司 用于制备诊断组合物的方法和试剂
US10575744B2 (en) 2017-02-24 2020-03-03 Medtronic Cryocath Lp Pericardial balloon mapping
CN109876157B (zh) * 2019-02-27 2020-12-15 浙江大学 离子特异性滤膜/介孔硅的复合材料、纳米传感器及其产品和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104352A (ja) * 1982-11-08 1984-06-16 ニユエガ−ド・アンド・コンパニ−・アクシエ・セルカペト X線造影剤
GB8906130D0 (en) 1989-03-17 1989-05-04 Nycomed As Compositions
GB9020091D0 (en) 1990-09-14 1990-10-24 Nycomed As Contrast media
DE4344464A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kaskadenpolymere mit Iodaromaten
GB9419203D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
US8066970B2 (en) * 2006-05-11 2011-11-29 Ge Healthcare As Contrast agents
KR20100033405A (ko) * 2007-07-12 2010-03-29 지이 헬스케어 에이에스 조영제

Also Published As

Publication number Publication date
US8815210B2 (en) 2014-08-26
CN102596257A (zh) 2012-07-18
AU2010311478B2 (en) 2015-09-24
BR112012009859A2 (pt) 2016-08-30
CA2773685A1 (en) 2011-05-05
IL218456A0 (en) 2012-04-30
NZ598540A (en) 2014-03-28
MX2012005021A (es) 2012-06-19
JP2013509378A (ja) 2013-03-14
CO6531477A2 (es) 2012-09-28
PT2493511E (pt) 2013-11-18
ZA201203505B (en) 2013-01-31
KR101545045B1 (ko) 2015-08-17
US20120328522A1 (en) 2012-12-27
HRP20130991T1 (hr) 2013-12-20
PL2493511T3 (pl) 2014-05-30
IL218456A (en) 2015-08-31
EP2493511B1 (en) 2013-10-16
BR112012009859B1 (pt) 2019-10-22
WO2011051387A1 (en) 2011-05-05
DK2493511T3 (da) 2013-11-25
ES2435299T3 (es) 2013-12-18
EP2493511A1 (en) 2012-09-05
KR20120091149A (ko) 2012-08-17
AU2010311478A1 (en) 2012-03-29
JP5335147B2 (ja) 2013-11-06
CA2773685C (en) 2016-05-31
RU2012116882A (ru) 2013-12-10
RU2544113C2 (ru) 2015-03-10
CN102596257B (zh) 2013-08-21

Similar Documents

Publication Publication Date Title
UA110943C2 (uk) N-ацилсульфонамідні промотори апоптозу
MX2011013648A (es) Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos.
IN2012DN02126A (es)
CL2011002255A1 (es) Compuestos derivados de 2-acetamino-5-aril-(1,2,4-triazolona o imidazolona), antagonista del receptor v1a y v2; composicion farmaceutica que los comprende; procedimiento de preparacion; y su uso en el tratamiento de insuficiencia cardiaca, hiponatremia hipervolemica y euvolemica, ascitis, ademas, entre otras.
UY29404A1 (es) Forma cristalina beta-d del clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmaceuticas que la contienen.
UY29406A1 (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen.
UA105911C2 (uk) Сульфонамідні похідні
SG165417A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
UA96076C2 (en) Use of trans-clomiphene
TW200637609A (en) Oxidation resistant dentifrice compositions
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2011006959A (es) Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MY157124A (en) Substituted imidazopyridinyl-aminopyridine compounds
MY151295A (en) Pyrimidyl indoline compound
MX2009005413A (es) Formas cristalinas del acido zoledronico.
MY156288A (en) Pharmaceutical formulations containing dopamine receptor ligands.
MX2009009153A (es) Pirano-pirazol-aminas.
MX2013012793A (es) Aminoacidos radiomarcados para imagen de diagnostico.
MX2009012472A (es) Combinacion que comprende acido pirrolidona-5-carboxilico y por lo menos un compuesto de citrulina, arginina y asparragina, y su uso en el tratamiento de dermatitis atopica.
TN2010000585A1 (en) Pharmaceutical compositions of rosuvastatin calcium
TW200833371A (en) Process for solid formulations
MX2012001921A (es) Diastereomeros simples de 4-fluoroglutamina y metodos para su preparacion y uso.
MX2011008195A (es) Derivados de indol como agentes anticancer.